MREO logo

Mereo BioPharma (MREO) Company Overview

Profile

Full Name:

Mereo BioPharma Group plc

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

April 24, 2019

Indexes:

Not included

Description:

Mereo BioPharma is a biopharmaceutical company focused on developing innovative treatments for rare diseases and cancer. They aim to improve patients' lives by advancing their drug candidates through clinical trials and bringing new therapies to market. Their work targets unmet medical needs in challenging health conditions.

Events Calendar

Earnings

Next earnings date:

Mar 27, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 Needham
Buy
Dec 24, 24 LifeSci Capital
Outperform
Dec 17, 24 Needham
Buy
Dec 6, 24 Jefferies
Buy
Nov 12, 24 Needham
Buy
Oct 1, 24 Cantor Fitzgerald
Overweight
Sep 16, 24 Cantor Fitzgerald
Overweight
Aug 13, 24 Needham
Buy
Jul 22, 24 Cantor Fitzgerald
Overweight
Jun 20, 24 Leerink Partners
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Mereo BioPharma?
  • Does Mereo BioPharma pay dividends?
  • What sector is Mereo BioPharma in?
  • What industry is Mereo BioPharma in?
  • What country is Mereo BioPharma based in?
  • When did Mereo BioPharma go public?
  • Is Mereo BioPharma in the S&P 500?
  • Is Mereo BioPharma in the NASDAQ 100?
  • Is Mereo BioPharma in the Dow Jones?
  • When was Mereo BioPharma's last earnings report?
  • When does Mereo BioPharma report earnings?
  • Should I buy Mereo BioPharma stock now?

What is the ticker symbol for Mereo BioPharma?

The ticker symbol for Mereo BioPharma is NASDAQ:MREO

Does Mereo BioPharma pay dividends?

No, Mereo BioPharma does not pay dividends

What sector is Mereo BioPharma in?

Mereo BioPharma is in the Healthcare sector

What industry is Mereo BioPharma in?

Mereo BioPharma is in the Biotechnology industry

What country is Mereo BioPharma based in?

Mereo BioPharma is headquartered in United Kingdom

When did Mereo BioPharma go public?

Mereo BioPharma's initial public offering (IPO) was on April 24, 2019

Is Mereo BioPharma in the S&P 500?

No, Mereo BioPharma is not included in the S&P 500 index

Is Mereo BioPharma in the NASDAQ 100?

No, Mereo BioPharma is not included in the NASDAQ 100 index

Is Mereo BioPharma in the Dow Jones?

No, Mereo BioPharma is not included in the Dow Jones index

When was Mereo BioPharma's last earnings report?

Mereo BioPharma's most recent earnings report was on Nov 12, 2024

When does Mereo BioPharma report earnings?

The next expected earnings date for Mereo BioPharma is Mar 27, 2025

Should I buy Mereo BioPharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions